Questions remain about the merits of asparaginase-based therapy
Radiation therapy produces anti-inflammatory response
Phase 1 study found mutant calreticulin-specific monoclonal antibody brings promising results with no dose-limiting toxicities
Two blood tests improve risk in assessment after ovarian ultrasound
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic psychiatrist urges integrating psychosocial care into oncology
A retrospective analysis
Simple score uses clinical factors to identify patients who might benefit from earlier screening
Noninvasive treatment may slow progression of Dupuytren's disease and plantar fibromatrosis
Age alone should not rule out patients from potentially curative treatment
Oncologic and functional outcomes are promising, but selection is key
Advertisement
Advertisement